Skip to content

Government calls for slash in price of anti-HIV jab

# The National Health Department criticises drug company ViiV Healthcare for pricing their anti-HIV jab at three times what the department can afford. ViiV sells the two-monthly anti-HIV jab for a range between 540 and 570 rand per shot, claiming it eliminates the risk of contracting HIV through sex. Khadija Jamaloodien, the department’s chief director of procurement, urges for a cost-effective approach, advocating for the jab to be priced reasonably, comparable to the daily oral pill at 129 rand for a two-month supply.